BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35589807)

  • 1. Identification of AKIRIN2 as a potential biomarker and correlation with immunotherapy in gastric adenocarcinoma by integrated bioinformatics analysis.
    Sun S; Chen J; Weng C; Lu Y; Cai C; Lv B
    Sci Rep; 2022 May; 12(1):8400. PubMed ID: 35589807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma.
    Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C
    Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.
    Ma W; Li W; Xu L; Liu L; Xia Y; Yang L; Da M
    Pathol Oncol Res; 2021; 27():1609852. PubMed ID: 34566519
    [No Abstract]   [Full Text] [Related]  

  • 4. Silencing immune-infiltrating biomarker CCDC80 inhibits malignant characterization and tumor formation in gastric cancer.
    Yu M; Peng J; Lu Y; Li S; Ding K
    BMC Cancer; 2024 Jun; 24(1):724. PubMed ID: 38872096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis-Related lncRNAs Act as Novel Prognostic Biomarkers in the Gastric Adenocarcinoma Microenvironment, Immunotherapy, and Chemotherapy.
    Zheng Y; Wu S; Huang X; Luo L
    Oxid Med Cell Longev; 2023; 2023():9598783. PubMed ID: 37251440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.
    Yin Z; Wu D; Shi J; Wei X; Jin N; Lu X; Ren X
    BMC Cancer; 2020 Nov; 20(1):1062. PubMed ID: 33148208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
    Wang Q; Liang J; Hu X; Gu S; Xu Q; Yan J
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology.
    Chen Z; Yu M; Yan J; Guo L; Zhang B; Liu S; Lei J; Zhang W; Zhou B; Gao J; Yang Z; Li X; Zhou J; Fan J; Ye Q; Li H; Xu Y; Xiao Y
    Front Immunol; 2021; 12():647209. PubMed ID: 33841428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioinformatics analysis of the prognosis and biological significance of VCAN in gastric cancer.
    Huang XY; Liu JJ; Liu X; Wang YH; Xiang W
    Immun Inflamm Dis; 2021 Jun; 9(2):547-559. PubMed ID: 33631054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
    Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway.
    Leng K; Xu Y; Kang P; Qin W; Cai H; Wang H; Ji D; Jiang X; Li J; Li Z; Huang L; Zhong X; Sun X; Wang Z; Cui Y
    Cell Death Dis; 2019 Mar; 10(4):262. PubMed ID: 30886152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
    Hu X; Wu L; Liu B; Chen K
    Front Immunol; 2021; 12():651056. PubMed ID: 34122409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
    Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
    Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
    Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
    Front Immunol; 2022; 13():854785. PubMed ID: 35392086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
    Ren N; Liang B; Li Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance and prognostic role of an immune-related gene signature in gastric adenocarcinoma.
    Mao R; Liu K; Zhao N; Guo P; Wu Y; Wang Z; Liu Y; Zhang T
    Aging (Albany NY); 2021 Jul; 13(13):17734-17767. PubMed ID: 34247148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma.
    Pasini FS; Zilberstein B; Snitcovsky I; Roela RA; Mangone FR; Ribeiro U; Nonogaki S; Brito GC; Callegari GD; Cecconello I; Alves VA; Eluf-Neto J; Chammas R; Federico MH
    J Gastroenterol; 2014 Nov; 49(11):1453-66. PubMed ID: 24217965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of nucleotide metabolism and neuroendocrine regulation-associated modification patterns in stomach adenocarcinoma with auxiliary prognostic assessment and immunotherapy response prediction.
    Zhang Y; Zeng L; Lin D; Chang G; Zeng Y; Xia Y
    Front Endocrinol (Lausanne); 2022; 13():1076521. PubMed ID: 36726460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.